Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights
International Journal of Molecular Sciences · 09.01.2024 · 25 (2) · 804
DOI: 10.3390/ijms25020804 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.01.2024. Verfasst von George Jia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine-Endocrinology and Metabolism, University of Missouri School of Medicine, Columbia, MO 65212, USA. Hauptthemen laut MEDLINE: Diabetic Angiopathies, Metabolic Syndrome, Peripheral Vascular Diseases, Insulin Resistance. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Clinical and basic studies have documented that both hyperglycemia and insulin-resistance/hyperinsulinemia not only constitute metabolic disorders contributing to cardiometabolic syndrome, but also predispose to diabetic vasculopathy, which refers to diabetes-mellitus-induced microvascular and macrovascular complications, including retinopathy, neuropathy, atherosclerosis, coronary artery disease, hypertension, and peripheral artery disease. The underlying molecular and cellular mechanisms include inappropriate activation of the renin angiotensin–aldosterone system, mitochondrial dysfunction, excessive oxidative stress, inflammation, dyslipidemia, and thrombosis. These abnormalities collectively promote metabolic disorders and further promote diabetic vasculopathy. Recent evidence has revealed that endothelial progenitor cell dysfunction, gut dysbiosis, and the abnormal release of extracellular vesicles and their carried microRNAs also contribute to the development and progression of diabetic vasculopathy. Therefore, clinical control and treatment of diabetes mellitus, as well as the development of novel therapeutic strategies are crucial in preventing cardiometabolic syndrome and related diabetic vasculopathy. The present review focuses on the relationship between insulin resistance and diabetes mellitus in diabetic vasculopathy and related cardiovascular disease, highlighting epidemiology and clinical characteristics, pathophysiology, and molecular mechanisms, as well as management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine-Endocrinology and Metabolism, University of Missouri School of Medicine, Columbia, MO 65212, USA.
- Department of Biology, Washington University in St Louis, St. Louis, MO 63130, USA.
- Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO 65212, USA.
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65212, USA.
ORCID-Profile: Guanghong Jia
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Heart, Lung, and Blood Institute
Zitieren
APA
Jia, G., Bai, H., Mather, B., Hill, M. A., Jia, G., & Sowers, J. R. (2024). Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights. International Journal of Molecular Sciences, 25(2), 804. https://doi.org/10.3390/ijms25020804
Vancouver
Jia G, Bai H, Mather B, Hill MA, Jia G, Sowers JR. Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights. International Journal of Molecular Sciences. 2024;25(2):804. doi:10.3390/ijms25020804
BibTeX
@article{Jia2024,
author = {Jia, George and Bai, Hetty and Mather, Bethany and Hill, Michael A and Jia, Guanghong and Sowers, James R},
title = {Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {2},
pages = {804},
doi = {10.3390/ijms25020804}
}
EUVIMED